EDGAR Filing Documents for 0001144204-15-059668

Form S-8 - Securities to be offered to employees in employee benefit plans:

SEC Accession No. 0001144204-15-059668

Filing Date

2015-10-16

Accepted

2015-10-15 19:03:15

Documents

Effectiveness Date

2015-10-16

Document Format Files

Seq	Description	Document	Type	Size
1	FORM S-8	v422210_s8.htm	S-8	51962
2	EXHIBIT 4.5	v422210_ex4-5.htm	EX-4.5	158606
3	EXHIBIT 5.1	v422210_ex5-1.htm	EX-5.1	48052
4	EXHIBIT 23.1	v422210_ex23-1.htm	EX-23.1	3438
5	EXHIBIT 23.2	v422210_ex23-2.htm	EX-23.2	4191
	Complete submission text file	0001144204-15-059668.txt		267442

Mailing Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018

Business Address 24 WEST 40TH STREET 8TH FLOOR NEW YORK NY 10018 (646) 350-0702

Akari Therapeutics Plc (Filer) CIK: 0001541157 (see all company filings)

IRS No.: 981034922 | State of Incorp.: X0
Type: S-8 | Act: 33 | File No.: 333-207444 | Film No.: 151160906
SIC: 2834 Pharmaceutical Preparations